Initial treatment with twice weekly etanercept (Enbrel), a tumour necrosis factor antagonist, achieves more rapid clearance of skin lesions than once weekly treatment in patients with active psoriasis and psoriatic arthritis, according to results from the PRESTA study reported recently in the British Medical Journal…

Title: Rash
Category: Diseases and Conditions
Created: 12/31/1997
Last Editorial Review: 2/24/2010

Title: Hives
Category: Diseases and Conditions
Created: 12/31/1997
Last Editorial Review: 2/24/2010

Enbrel is the trade name for Etanercept, a medication used for treating autoimmune diseases. Enbrel is a TNF (tumor necrosis factor) inhibitor; it interferes with TNF…

Title: Health Tip: Avoid Triggers for Eczema
Category: Health News
Created: 2/22/2010 8:10:00 AM
Last Editorial Review: 2/22/2010